Zevra Therapeutics Inc (FRA:1GDA)
€ 5.75 0 (0%) Market Cap: 380.69 Mil Enterprise Value: 389.88 Mil PE Ratio: 0 PB Ratio: 10.13 GF Score: 51/100

Zevra Therapeutics Inc To Acquire Acer Therapeutics Inc Transcript

Aug 31, 2023 / 12:30PM GMT
Release Date Price: €4.8 (-0.41%)
Operator

Good morning, everyone and thank you for joining the Zevra Therapeutics Corporate Update Call to announce the acquisition of Acer Therapeutics. (Operator Instructions)

Today's call is being recorded and will be made available on the company's website following the conclusion of the call. With that, I'll now turn the call over to Nichol Ochsner, Vice President of Investor Relations and Corporate Communications for Zevra Therapeutics. Thank you. You may begin.

Nichol L. Ochsner
Zevra Therapeutics, Inc. - VP of IR & Corporate Communications

Good morning and thank you for joining us today as we discuss Zevra Therapeutics acquisition of Acer Therapeutics. Before we get started, let me take a moment to provide some important information. First, I encourage you to access the webcast slides in the press release, both of which were released this morning and are available in the Investors section of the Zevra website.

Today's discussion will include forward-looking statements. These encompass various topics, including updates on clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot